FTC clears sale of Bristol-Myers unit

01/8/2008 | Boston Globe (tiered subscription model), The

The Federal Trade Commission said it has approved the sale of Bristol-Myers Squibb Co.'s medical-imaging unit to private-equity firm Avista Capital Partners for $525 million. The sale, which was announced by Bristol-Myers last month, is part of the company's restructuring efforts to focus on pharmaceuticals.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC